http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2019203428-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc60039b5822cf6f878b02ff2e7a0141
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-0026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0004
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-025
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-12
filingDate 2019-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5501fe93fe70cd0702b4dffaba7ed81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_776fa0357b75122b7285f43123ae8744
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25775c6fb61496c3bcda8a61089fc025
publicationDate 2019-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2019203428-A1
titleOfInvention Expandable breast implant
abstract An expandable breast implant eliminates the need for multiple procedures and injections and is also capable of self-administered or automatic expansion that is safe in any environment. The expandable breast implant design includes an upper matrix, a lower matrix, and a middle layer. The upper matrix comprises a plurality of cells containing a first reagent. The lower matrix comprises a plurality of wells containing a second reagent. The middle layer acts as a barrier between the upper matrix and the lower matrix. The middle layer may be activated and controlled to form openings. The first reagent from the cells in the upper matrix mixes with the second reagent from the wells in the lower matrix through the selected openings in the middle layer. The reagents react to form a gas that permeates through a hydrophobic membrane into an expandable shell to enlarge the breast implant. -16- 130 150 135 00000 00000 00000 00000 00000 || 00000
priorityDate 2018-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892

Total number of triples: 31.